Elevate Capital Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Elevate Capital Advisors’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.01M	Buy	+17,206	New	+$994K	0.58%	43

Other funds holding RXL

Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

FAI Advisors Farmington Hills, Michigan $257M AUM 20.66% 1-Year Est. Return

Capital Investment Advisory Services Raleigh, North Carolina $1.61B AUM 16.94% 1-Year Est. Return

Bartlett & Co Wealth Management Cincinnati, Ohio $8.23B AUM 17.87% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.5B AUM 28.07% 1-Year Est. Return

Elevate Capital Advisors's RXL Position: Q3 2026 in Review

Elevate Capital Advisors opened a new position in ProShares Ultra Health Care (RXL) in Q3 2026: 17,206 shares worth $1.01M. The stake represents 0.58% of the portfolio and ranks #43 among its holdings.

13 funds tracked by Wall St. Rank hold RXL as of Q3 2026.

Elevate Capital Advisors held 17,206 shares of ProShares Ultra Health Care worth $1.01M as of Q3 2026.
ProShares Ultra Health Care was a new Elevate Capital Advisors position in Q3 2026.
ProShares Ultra Health Care made up 0.58% of Elevate Capital Advisors's portfolio in Q3 2026, its #43 holding.
13 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q3 2026.

Based on Elevate Capital Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.